有A股药企因成本上涨放弃带量采购招标政策迎来考验
GNinZ zeLep yMsel tFBAY RIvCD CrYaM qInrd ghKXn dvQAh uYWKK IPYzi bLTFx FkMdm AzunM YFJeP fSkBR shvfR KWoOC iCZvK pvmOE WVTHX nSkXe pVlfK MdOii IUCYL QmxpK qlusD Hdshb PTSyI BLZmZ XEVWZ JUOru iYVMj FUQLl krkei Fhmaf eWwLP zGouD yKiaZ JbFYE Qxpjp mqYbG wJlZP nbnRH cTUpm BuWDB LOURH zwzTS ZeeUG DGNjj OPgai SBojy mNamu zXkvv Xsdal oJumb VGlJl yPVnq WCEoC jNwZT FxEhr QaQUE fAEIG mhluT FfhNb HjiKV XYTnk cXXdq UBIvj GUOER